BBC

Virtus LifeSci Biotech Clinical Trials ETF

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.


US

EQUITY

Rules-Based

MANAGEMENT STYLE

11.7 M

ASSETS UNDER MGMT

79 bp

EXPENSES
Fund Basics
Fund sponsorETFis Capital LLC
CategoryUS
Asset classEquity
Websitelink...
Inception dateDec 16, 2014
Assets (mns)$12
Expense ratio79 bp
CurrencyUSD
Sector Breakdown
Fund Structure
RegulationOpen-Ended Fund
DistributionsAnnually
Taxation1099
Stock selectionProprietary
WeightingEqual
Holdings TransparencyFull
Derivatives-basedNo
Options availableYes
Currency hedgedNo
Fund of fundsNo
Top 10 Holdings
MORPHIC HOLDING, INC. 1.6 %
LONGBOARD PHARMACEUTICALS, INC. 1.4 %
ACELYRIN, INC. 1.2 %
UNIQURE N.V. 1.2 %
ORIC PHARMACEUTICALS INC 1.2 %
ANAPTYSBIO, INC. 1.2 %
ERASCA, INC. 1.1 %
SUMMIT THERAPEUTICS INC 1.1 %
IGM BIOSCIENCES, INC. 1.1 %
DYNE THERAPEUTICS INC 1.0 %
Constituent Breakdown
Number of holdings122
Herfindahl-Hirschman Index 85
Wgt avg mkt cap (mns)$905
Large cap (>$10bn)0.0%
Mid cap ($2-10bn)18.6%
Small cap (<$2bn)75.5%
Developed mkts.100.0%
Emerging mkts.0.0%
Country Exposure
UNITED STATES 72.6 %
NETHERLANDS 1.9 %
CANADA 1.7 %
GERMANY 1.4 %
IRELAND 0.9 %
SWITZERLAND 0.8 %
BRITAIN 0.8 %
SINGAPORE 0.8 %
Historical Performance


Standardized Performance (as of 10/31/2024)
 YTD1 YR2 YR3 YR5 YR10 YRIncep.
Total Returns 20.0% 64.9% 6.7% -12.8% 2.2% -- 0.8%
Volatility 33.9% 35.1% 34.1% 40.6% 40.2% -- --
Market Correlations
versus...BetaR-squared
S&P 5000.9923%
MSCI EAFE0.8618%
MSCI Emg Mkts0.629%
Liquidity Measures
Avg. volume (000)2
Turnover0.5%
Avg. Bid/Ask (% of price)0.25%
ADV of underlying (mns)$1,658
Technical Indicators
Recent close$29.28
30d moving avg.$28.70
Annualized volatility35.9%
Relative strength (RSI)50
Short interest (ETF)0.9%
Short interest (underlying)8.2%
Distributions
Assets Under Management (mns)

Money Flows (mns)

Short Interest (as % of shares outstanding)

Long Money Flows (mns)

Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial

Comparable ETFs Based on Overlap
Risk and Returns: BBC vs. Comps (1 YR)

Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Results & Estimates
  2019 2020 2021 2022 2023 2024E 2025E  
Sales per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Earnings per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Dividends per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Book value per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Valuation Metrics
  2023 2024E Fwd Est 2025E
Price-to-sales --x --x --x --x
Price-to-earnings --x --x --x --x
Price-to-cash flow --x --x --x --x
Price-to-growth --x --x --x --x
Price-to-book value --x --x --x --x
Yield --% --% --x --%
13.1 -5.5 -11.5 1.6% --
Based on closing prices from 11/13/2024
Historical Valuation Trends Sample data. Subscribe for access.

SHOWING:
Price-to-Earnings
BBC



Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.

Some content on this tab for Individual & Professional subscribers only. Start your FREE trial

ETF Research Center Rating

AVOID

Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may be less relevant.

ALTAR Score™

BBC

0.0%

Cat. Avg

5.4%


ALTAR Score™ Calculation

Category Overview
There are 973 funds in the US Equity category, with an average ALTAR Score™ of 5.4% and a standard deviation of 2.4%. BBC's ALTAR Score™ is approximately 2.2 standard deviations below the category average. This places BBC in the 1st percentile among funds in the category.
Sell Side Consensus Rating

Sell-side recommendations on the ETF's individual constituents

BBC
Peer Average
SELL
U/W
HOLD
O/W
BUY
Factor Scorecard

SIZE
VALUE
YIELD
MOMENTUM
VOLATILITY
QUALITY
Expense Analysis

Peer Group Rules-Based
US Equity ETFs
# of ETFs 609
Avg. Expense Ratio 46.6 bp
Std. Deviation 32.9 bp
BBC (79 bp) Percentile rank 84
Peer Group Expense Ratio Distribution


Total Cost of Ownership (TCO) Comparison
Expense (bp)
(A)
Avg. Bid/Ask (bp)
(B)
TCO (bp)
(A)+(B)
BBC 79.0 24.9 103.9
Peer Avg. 35.3 15.0 50.3
  For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .